Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/1997
05/27/1997US5633284 Nitrous oxide containing dermatological composition
05/27/1997US5633279 5-substituted derivatives of mycophenolic acid
05/27/1997US5633241 Administering as antileukemia agent
05/27/1997US5632997 Method of treating liver disfunction in mammals, using active principle isolated from shark tissue
05/22/1997WO1997018312A1 Chimeric oligomers having an rna-cleavage activity
05/22/1997WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
05/22/1997WO1997018223A1 Improved method and agents for inhibiting protein aging
05/22/1997WO1997018192A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments
05/22/1997WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia
05/22/1997CA2237565A1 Improved method and agents for inhibiting protein aging
05/22/1997CA2237528A1 Chimeric oligomers having an rna-cleavage activity
05/21/1997EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin
05/21/1997EP0774249A2 Topical composition containing specific flavanones
05/21/1997EP0773958A1 PTH OR PTHrP ANTAGONISTS
05/21/1997EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/21/1997EP0773795A1 Antifungal-wound healing compositions and methods for preparing and using same
05/21/1997EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases
05/21/1997EP0660718A4 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium.
05/21/1997EP0580738B1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
05/21/1997CN1150428A Corticotropin releasing factor antagonists
05/21/1997CN1150425A Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
05/21/1997CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids
05/21/1997CN1150043A Efficient low-side effect external use medicine for curing seborrheic baldness
05/21/1997CN1150018A Multifunctional Chinese medicine facial mask and prescription
05/21/1997CN1150016A Folium mori extract shampoo
05/20/1997US5631267 Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics
05/20/1997US5631019 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
05/20/1997US5631011 Hyaluronic acid or derivative; wound healing agents
05/15/1997WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
05/15/1997WO1997017077A1 Topical composition containing capsazepine
05/15/1997WO1997017061A1 Therapeutic preparation for the transdermal administration of active substances
05/15/1997CA2234797A1 Topical composition containing capsazepine
05/14/1997EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases
05/14/1997EP0772619A1 Immunomodulatory oligonucleotides
05/14/1997EP0772610A1 Dihydrobenzofuranes
05/14/1997EP0772594A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
05/14/1997EP0772447A1 Chinese herbs extract
05/14/1997EP0772446A1 Anti-adhesion agent
05/14/1997EP0772438A1 Methods of reducing scarring in wound healing
05/14/1997CN1034869C Peptide compound and its preparing method for pharmaceutical salt
05/14/1997CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound
05/13/1997US5629337 Methods for treating asthma using optically pure (-)-zileuton
05/13/1997US5629327 Methods and compositions for inhibition of angiogenesis
05/13/1997US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor
05/13/1997US5629301 Comprising salicylic acid, a surfactant and a carrier; cleaning compounds
05/13/1997US5629292 Use of angiotensin III and analogs thereof in tissue repair
05/13/1997US5629006 Skin disinfecting formulations
05/13/1997US5629004 Emulsion containing stabilized ascorbic acid, cosmetic treatment process using it and uses thereof
05/13/1997US5628988 Sunscreen agents
05/13/1997CA2033183C Water-soluble vitamin a preparations for application to the skin
05/09/1997WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
05/09/1997WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
05/09/1997WO1997016423A1 24-homo-26,27-hexafluoro-cholecalciferols
05/09/1997WO1997016197A1 Extracts of shark cartilage
05/09/1997WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases
05/09/1997WO1997016165A1 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration
05/09/1997CA2235584A1 24-homo-26,27-hexafluoro-cholecalciferols
05/09/1997CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
05/07/1997EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines
05/07/1997EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions
05/07/1997EP0771789A1 1 alpha, 26-dihydroxy-D-homo-vitamin D3
05/07/1997EP0771557A1 Use of ascorbic acid as the actif for the treatment of seborrhea in a cosmetic and/or dermatalogical composition
05/07/1997EP0771216A1 Methods and compositions for the specific coagulation of vasculature
05/07/1997EP0771203A1 Method of treating sweat-related conditions
05/07/1997EP0771191A1 Immunological activity of rhamnolipids
05/07/1997EP0771188A2 Soap composition
05/07/1997EP0756479A4 Gentle anti-acne composition
05/07/1997EP0628305B1 Stable oil-in-water emulsion type cosmetic or dermatologic composition containing at least one vegetable oil comprising at least 40% triglycerides derived from linolic acid
05/07/1997EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene
05/07/1997DE19541260A1 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut Therapeutic composition for transdermal administration of drugs through the skin
05/07/1997CN1149295A Tricyclic Dicarbonyl derivatives
05/07/1997CN1149288A Vitamin-D amide derivatives
05/07/1997CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
05/07/1997CN1149250A Improved anti-dandruff shampoo
05/07/1997CN1148986A New skin preparation composition
05/07/1997CN1148975A Ointment for anti-inflammatory and curing burn
05/07/1997CN1148974A Oral liquid for health-care and skin-nursing
05/07/1997CN1148972A Oral liquid for curing hand and foot chapping
05/06/1997US5627212 Esters of L-carnitine and acyl L-carnitine with hydoxy acids for producing pharmcaeutical compositions for treating dermatoses
05/06/1997US5626855 Serine compounds, their preparation and their use in cosmetic or dermatological compositions
05/03/1997CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
05/02/1997EP0770395A1 Use of botulinum toxins for treating headache
05/02/1997EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition
05/02/1997EP0770129A1 Zinc finger protein derivatives and methods therefor
05/02/1997EP0770059A1 Substituted benzamidines, their production and their use as medicaments
05/02/1997EP0770058A1 Novel chemical compound, its preparation and use as a drug
05/02/1997EP0769961A1 Attenuation of wound healing processes
05/02/1997EP0769950A1 Method and compound for the treatment of hair loss
05/02/1997EP0769947A1 Indolinone compounds for the treatment of disease
05/02/1997EP0328552B2 Thrombin derived polypeptides, compositions and methods for use
05/01/1997WO1997015662A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
05/01/1997WO1997015321A1 Pharmaceutical composition containing an activin or inhibin stimulator
05/01/1997WO1997015313A1 Therapeutic use of hemoglobin in promoting wound healing
05/01/1997WO1997015282A1 Compositions for the treatment of dermatological disorders and methods for their use
05/01/1997WO1997015281A1 Use of at least one beta-adrenergic agonist as a p substance antagonist
05/01/1997WO1997015280A1 Use of at least one no synthase inhibitor for treating sensitive skin
05/01/1997WO1997015195A1 Hybrid matrix implants and explants
05/01/1997WO1997012601A3 Gel formulations containing growth factors
05/01/1997CA2235548A1 Therapeutic use of hemoglobin in promoting wound healing
05/01/1997CA2235368A1 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor